IKON Group Investments — Global Holdings Company

IKON Market Brief: As AI scribe adoption grows, researchers at Suki challenge the industry's quality playbook

Posted by:

|

On:

|

As adoption of AI ambient scribe technology rapidly grows, the healthcare industry’s standard method for evaluating clinical AI notes may be fundamentally flawed, failing to detect significant errors in patient notes.

Source: www.fiercehealthcare.com

IKON Portfolio Context

Kynetide Peptides supplies 99%+ HPLC-verified research compounds with batch-specific COAs to 2,400+ researchers worldwide.

Posted by

in